Drug firm Pfizer today reported a 21.98 per cent dip in its standalone net profit at Rs 68.04 crore for the fourth quarter ended March 31, 2017.
The company had posted a net profit of Rs 87.21 crore for the corresponding period of the previous fiscal, Pfizer Ltd said in a filing to BSE.
Standalone total income of the company for the quarter under consideration stood at Rs 481.97 crore as against Rs 563.57 crore in the same period a year ago.
For the fiscal year ended March 31, the net profit of the company stood at Rs 336.78 crore. It was Rs 304.99 crore during the preceding fiscal.
Total income of the company stood at Rs 2,143.09 crore for the fiscal year ended March 31.
Its total income during 2015-16 fiscal was at Rs 2,180.75 crore.
The board of directors of the company has recommended a normal dividend of Rs 15 per equity share of Rs 10 each and a special dividend of Rs 5 per share of Rs 10 each on account of exceptional income during the year for the financial year ended March 31, Pfizer said.